Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
March 4 (Reuters) - Syndax Pharmaceuticals Inc SNDX.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.